Methods for treating pathologies
AssigneeOmega Pharmaceutical, Inc.
InventorsThomas W. Hodge, David W. Boykin
Life of this patent
Estimating the term…
Abstract
The invention provides a method of modulating the immune system. Also provided is a method of treating a pathology associated with increased levels of a tumor necrosis factor. The invention further provides a method of treating a pathology resulting from infection by human immunodeficiency virus. Also provided is a method of treating chronic graft vs. host disease. Finally, the invention provides a method of promoting wound healing in a subject.
Claims30
A method of modulating the immune system in a subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 18
- and derivatives or analogs thereof.
A method of modulating the immune system in a subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 19
- and derivatives or analogs thereof.
A method of modulating the immune system in a subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 20
- and derivatives or analogs thereof.
A method of modulating the immune system in a subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 21
- and derivatives or analogs thereof.
A method of modulating the immune system in a subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 22
- and derivatives or analogs thereof.
A method of modulating the immune system in a subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 23
- and derivatives or analogs thereof.
A method of modulating the immune system in a subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 24
- and derivatives or analogs thereof.
A method of modulating the immune system in a subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 25
- and derivatives or analogs thereof.
A method of modulating the immune system in a subject comprising administering to the subject a therapeutic amount of the compound having the structural formula:and derivatives or analogs thereof.
- 26
- and derivatives or analogs thereof.
A method of modulating the immune system in a subject comprising administering to the subject a therapeutic amount of the compound having the structural formula:and derivatives or analogs thereof.
- 27
- and derivatives or analogs thereof.
A method of treating a pathology associated with increased levels of a tumor necrosis factor comprising administering to the subject a compound having the structural formula
- 28
A method of treating a pathology associated with increased levels of a tumor necrosis factor comprising administering to the subject a compound having structural formula
- 29
A method of treating a pathology associated with increased levels of a tumor necrosis factor comprising administering to the subject a compound having the structural formula
- 30
A method of treating a pathology associated with increased levels of a tumor necrosis factor comprising administering to the subject a compound having the structural formula
- 31
A method of treating a pathology associated with increased levels of a tumor necrosis factor comprising administering to the subject a compound having the structural formula
- 32
A method of treating a pathology associated with increased levels of a tumor necrosis factor comprising administering to the subject a compound having the structural formula
- 33
A method of treating a pathology associated with increased levels of a tumor necrosis factor comprising administering to the subject a compound having the structural formula
- 34
A method of treating a pathology associated with increased levels of a tumor necrosis factor comprising administering to the subject a compound having the structural formula
- 35
A method of treating a pathology associated with increased levels of a tumor necrosis factor comprising administering to the subject a compound having the structural formula
- 36
A method of treating a pathology associated with increased levels of a tumor necrosis factor comprising administering to the subject a compound having the structural formula
- 37
A method of treating a pathology resulting from infection by human immunodeficiency virus in a human subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 38
- and derivatives or analogs thereof.
A method of treating a pathology resulting from infection by human immunodeficiency virus in a human subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 39
- and derivatives or analogs thereof.
A method of treating a pathology resulting from infection by human immunodeficiency virus in a human subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 40
- and derivatives or analogs thereof.
A method of treating a pathology resulting from infection by human immunodeficiency virus in a human subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 41
- and derivatives or analogs thereof.
A method of treating a pathology resulting from infection by human immunodeficiency virus in a human subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 42
- and derivatives or analogs thereof.
A method of treating a pathology resulting from infection by human immunodeficiency virus in a human subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 43
- and derivatives or analogs thereof.
A method of treating a pathology resulting from infection by human immunodeficiency virus in a human subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 44
- and derivatives or analogs thereof.
A method of treating a pathology resulting from infection by human immunodeficiency virus in a human subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 45
- and derivatives or analogs thereof.
A method of treating a pathology resulting from infection by human immunodeficiency virus in a human subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 46
- and derivatives or analogs thereof.
A method of treating a pathology resulting from infection by human immunodeficiency virus in a human subject comprising administering to the subject a therapeutic amount of the compound having the structural formula
- 47
- and derivatives or analogs thereof.
Dependencies are inferred from the claim text.